verapamil has been researched along with Vascular Diseases in 11 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine is a safe and effective alternative of verapamil in preventing spasm of radial artery conduit." | 6.90 | Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil. ( Haanschoten, M; Özdemir, AB; Özdemir, HI; Soliman-Hamad, MA; van Dijk, CHB; van Straten, BHM, 2019) |
| "We compared the chronic effects in spontaneously hypertensive rats (SHR) of low doses of an angiotensin converting enzyme inhibitor, trandolapril, a Ca2+ channel antagonist, verapamil, and their combination (trandolapril-verapamil), on arterial mechanical properties, arterial wall hypertrophy and extracellular matrix proteins." | 3.70 | Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. ( Benetos, A; Kirchengaast, M; Koffi, I; Lacolley, P; Laurent, S; Pomiès, JP, 1998) |
| "Nicardipine is a safe and effective alternative of verapamil in preventing spasm of radial artery conduit." | 2.90 | Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil. ( Haanschoten, M; Özdemir, AB; Özdemir, HI; Soliman-Hamad, MA; van Dijk, CHB; van Straten, BHM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özdemir, HI | 1 |
| van Dijk, CHB | 1 |
| Özdemir, AB | 1 |
| van Straten, BHM | 1 |
| Haanschoten, M | 1 |
| Soliman-Hamad, MA | 1 |
| Tarhan, IA | 1 |
| Kehlibar, T | 1 |
| Arslan, Y | 1 |
| Yilmaz, M | 1 |
| Dumantepe, M | 1 |
| Berkoz, K | 1 |
| Pancaroglu, C | 1 |
| Ozler, A | 1 |
| Koffi, I | 1 |
| Lacolley, P | 1 |
| Kirchengaast, M | 1 |
| Pomiès, JP | 1 |
| Laurent, S | 1 |
| Benetos, A | 1 |
| Ruschitzka, F | 1 |
| Quaschning, T | 1 |
| Noll, G | 1 |
| deGottardi, A | 1 |
| Rossier, MF | 1 |
| Enseleit, F | 1 |
| Hürlimann, D | 1 |
| Lüscher, TF | 1 |
| Shaw, SG | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Rippmann, ET | 1 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| LeVeen, RF | 1 |
| Wolf, GL | 1 |
| Biery, D | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Nissen, P | 1 |
| Alexander, K | 1 |
| Nedden, KH | 1 |
| Fabel, H | 1 |
| Svecov, IM | 1 |
| Derzavez, LC | 1 |
| Krutik, IG | 1 |
| Culkova, IP | 1 |
| Dobrochotov, GS | 1 |
3 reviews available for verapamil and Vascular Diseases
| Article | Year |
|---|---|
[Calcium antagonists in cardiology].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Human | 1978 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
2 trials available for verapamil and Vascular Diseases
| Article | Year |
|---|---|
Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil.
Topics: Administration, Topical; Calcium Channel Blockers; Coronary Artery Bypass; Female; Humans; Linear Mo | 2019 |
Effects of normothermic organ bath and verapamil-nitroglycerin solution alone or in combination on the blood flow of radial artery.
Topics: Adult; Aged; Body Temperature; Drug Combinations; Female; Humans; Hypothermia, Induced; Male; Middle | 2007 |
6 other studies available for verapamil and Vascular Diseases
| Article | Year |
|---|---|
Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, CD; Aorta, Thoracic; Arteries; Blood Pr | 1998 |
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acetylcholine; Animals; Blood Pressure; Body Weight; Cells, C | 2001 |
[Beta-sympathomimetics, causal treatment of EPH-gestosis (author's transl)].
Topics: Capillaries; Drug Therapy, Combination; Female; Humans; Pregnancy; Pregnancy Complications, Cardiova | 1976 |
Angioplasty-induced vasospasm in rabbit model. Mechanisms and treatment.
Topics: Angioplasty, Balloon; Animals; Extravasation of Diagnostic and Therapeutic Materials; Femoral Artery | 1985 |
[Drug therapy of chronic arterial occlusion of the extremities by intraarterial administration of Verapramil].
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Electrocardiography; Femoral Artery; Heart Rate; Human | 1972 |
[Behavior of the microcirculation in the experimental treatment of coronary insufficiency with verapamil and the clinical use of verapamil in revascularization of the heart].
Topics: Animals; Anti-Arrhythmia Agents; Blood Circulation; Capillaries; Collateral Circulation; Coronary Di | 1970 |